Dr Polius Raslavicius, MD | |
789 Central Ave, Wentworth-douglass Hospital, Dover, NH 03820-2526 | |
(603) 335-2338 | |
Not Available |
Full Name | Dr Polius Raslavicius |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 789 Central Ave, Dover, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619960333 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 5076 (New Hampshire) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Polius Raslavicius, MD 253 North Shore Rd, New Durham, NH 03855 Ph: () - | Dr Polius Raslavicius, MD 789 Central Ave, Wentworth-douglass Hospital, Dover, NH 03820-2526 Ph: (603) 335-2338 |
News Archive
A weight-loss drug dampened the response to food cues in regions of the brain associated with attention and emotion, leading to decreases in caloric intake, weight and body mass index (BMI), a team led by scientists at Beth Israel Deaconess Medical Center reported.
CEL-SCI Corporation announced today it has received approval from the first Taiwanese Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Scientists at Dana-Farber Cancer Institute have shown in a laboratory study that revving up a crucial set of muscle genes counteracts the damage caused by a form of muscular dystrophy.
Personalised medicine is a field that holds a lot of promise as a provider of practices and technology that could help develop more effective treatments for serious diseases such as cancer. Personalised medicine involves tailoring treatment according to the genetic profile and molecular makeup of each patient.
The American Hospital Association is lobbying to raise the program's eligibility age from 65 to 67 as a means of heading off additional cuts to Medicare hospital payments. Meanwhile, some conservatives view the program's fiscal challenges as the problem that stands above all others.
› Verified 2 days ago
David A Novis, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-742-2132 | |
Glenn Harold Littell, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-742-2132 | |
Dr. Lucy Harn Kapur, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-742-5252 |